3-Cyclopentyl-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole

Catalog No.: 
ACOWQL392
CAS No.: 
1542390-42-0
Molecular Formula: 
C13H21N3O
Molecular Weight: 
235.33
3-Cyclopentyl-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$141.00In stockInquiry
250mg95%$239.00In stockInquiry
1g95%$644.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Cyclopentyl-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole
IUPAC Name3-cyclopentyl-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole
MDL No.MFCD24883093
Molecular FormulaC13H21N3O
Molecular Weight235.33
SMILESC1(CC2=NC(C3CCCC3)=NO2)CCNCC1
InChI KeyOXZIEYMBLZWYKZ-UHFFFAOYSA-N
SynonymPiperidine, 4-[(3-cyclopentyl-1,2,4-oxadiazol-5-yl)methyl]-;4-[(3-Cyclopentyl-1,2,4-oxadiazol-5-yl)methyl]piperidine;3-Cyclopentyl-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole
CAS No.1542390-42-0
PubChem CID79608733

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOWQL392 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQL392 route product structure diagram
    ACOWQL3921542390-42-0In Stock
Inquiry

2. ACOWQL392 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQL392 route product structure diagram
    ACOWQL3921542390-42-0In Stock
Inquiry

3. ACOWQL392 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOWQL392 route product structure diagram
    ACOWQL3921542390-42-0In Stock
Inquiry

Comments (0)